DeutschNewstral
Article
bizjournals.com on 2015-08-11 19:18
What’s ‘gene editing’ and why are investors putting $120M toward it? (Video)
Related news
Gene editing holds huge promise, but what’s ethical?seattletimes.com- FCrispr gene editing ready for testing in humansft.com
The promise of gene editingBBC
Legal battle gives Broad Institute control of patent for CRISPR/Cas9 gene-editing processThe Japan Times
How the Vatican approaches gene editing, life extension, and stem cell researchhowwegettonext.com
Will Moderna’s Interest Boost Gene Editing Stocks?Forbes
Can gene editing eliminate deadly diseases?Al Jazeera
Swift Gene-Editing Method May Revolutionize TreatmentsThe New York Times- NSimple technology makes CRISPR gene editing cheapernews.berkeley.edu
- Boom in gene-editing raises ethics debateThe Japan Times
- TFeature: Can gene editing kill deadly diseases?thechronicle.com.gh
- PResearch institute retains gene editing patent rightsproducer.com
Firms pour cash into gene editingBoston Herald- DUC obtains 8th patent for CRISPR gene-editing methodsdailycal.org
- DUC awarded 12th patent for CRISPR-Cas9 gene-editing technologydailycal.org
CRISPR’s Nobel Prize sent gene-editing stocks into overdrivethenextweb.com- Intellia, Editas: How Are Gene Editing Stocks Faring?Forbes
- Human Cells Can Resist Gene-Editing Tools Like CrisprThe New York Times
- CRISPR Gene Editing Problems: Does It Really Cause Unexpected Mutations?Forbes
A Patent Decision on Crispr Gene Editing Favors MITWired.com